Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.
Saved in:
| Title: | Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. |
|---|---|
| Authors: | Vergara IA; Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Melanoma Institute of Australia, Sydney, Australia., Mintoff CP; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., McIntosh L; Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Mathematics and Statistics, The University of Melbourne, Parkville, VIC, Australia., Young RJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Wong SQ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Colebatch A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Cameron DL; Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia., Kwon JL; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Wolfe R; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Peng A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia., Ellul J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Dou X; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Fedele C; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Boyle S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Arnau GM; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Raleigh J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Hatzimihalis A; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Szeto P; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia., Mooi J; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Widmer DS; Department of Dermatology, University of Zürich Hospital, Zürich, Switzerland., Cheng PF; Department of Dermatology, University of Zürich Hospital, Zürich, Switzerland., Amann V; Department of Dermatology, University of Zürich Hospital, Zürich, Switzerland., Dummer R; Department of Dermatology, University of Zürich Hospital, Zürich, Switzerland., Hayward N; Melanoma Institute of Australia, Sydney, Australia.; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Wilmott J; Melanoma Institute of Australia, Sydney, Australia., Scolyer RA; Melanoma Institute of Australia, Sydney, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia., Cho RJ; Department of Dermatology, University of California, San Francisco, CA, USA., Bowtell D; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Thorne H; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Alsop K; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Cordner S; The Victorian Institute of Forensic Medicine, Melbourne, Australia., Woodford N; The Victorian Institute of Forensic Medicine, Melbourne, Australia., Leditschke J; The Victorian Institute of Forensic Medicine, Melbourne, Australia., O'Brien P; The Victorian Institute of Forensic Medicine, Melbourne, Australia., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Centre of Cancer Research, The University of Melbourne, Parkville, VIC, Australia., McArthur GA; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia., Mann GJ; Melanoma Institute of Australia, Sydney, Australia.; Centre for Cancer Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia., Levesque MP; Department of Dermatology, University of Zürich Hospital, Zürich, Switzerland., Papenfuss AT; Bioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. papenfuss@wehi.edu.au.; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. papenfuss@wehi.edu.au.; Department of Mathematics and Statistics, The University of Melbourne, Parkville, VIC, Australia. papenfuss@wehi.edu.au.; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. papenfuss@wehi.edu.au.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. papenfuss@wehi.edu.au., Shackleton M; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. mark.shackleton@monash.edu.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. mark.shackleton@monash.edu.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia. mark.shackleton@monash.edu.; Department of Oncology, Alfred Health, Melbourne, Australia. mark.shackleton@monash.edu. |
| Source: | Nature communications [Nat Commun] 2021 Mar 04; Vol. 12 (1), pp. 1434. Date of Electronic Publication: 2021 Mar 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
